Skip to main content

Main menu

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Other Publications
    • NeuroSciences Journal

User menu

  • My alerts
  • Log in

Search

  • Advanced search
Saudi Medical Journal
  • Other Publications
    • NeuroSciences Journal
  • My alerts
  • Log in
Saudi Medical Journal

Advanced Search

  • Home
  • Content
    • Latest
    • Archive
    • home
  • Info for
    • Authors
    • Reviewers
    • Subscribers
    • Institutions
    • Advertisers
    • Join SMJ
  • About Us
    • About Us
    • Editorial Office
    • Editorial Board
  • More
    • Advertising
    • Alerts
    • Feedback
    • Folders
    • Help
  • Follow psmmc on Twitter
  • Visit psmmc on Facebook
  • RSS
AbstractAbstract
Open Access

In this issueREVIEW ARTICLEORIGINAL ARTICLESCASE REPORT

Saudi Medical Journal March 2015, 36 (3) 271;
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • References
  • PDF
Loading

REVIEW ARTICLE

CD44 as a potential diagnostic tumor marker

This review of Baskran focuses on CD44 prevalence in cancer cells. It considers tumorigenic behavior of cells that highly express CD44 as an early marker for neoplastic stem cell proliferation. The author discusses multiple examples of tumor, with an emphasis on 2 solid tumors; namely, breast and colon cancer. Tumors of epithelial origin express CD44 in multiple isoforms called variants; some isoforms are related to specific cancer cells. An increase of CD44 specific isoforms is detected in certain leukemic proliferations. He concludes that CD44 could be a diagnostic marker for specific cancer cells. The CD44 also can be employed as a therapeutic alternative for eradicating or sensitizing cancer cells for chemotherapy.

see page 273

ORIGINAL ARTICLES

The effects of probiotics on treatment of Helicobacter pylori eradication in children

In this study, Akcam et al found no evidence in terms of eradication of Helicobacter pylori (H. pylori), or impact on adverse effects obtained after the addition of probiotics to standard treatment. Larger randomized controlled investigations are needed to clearly understand the effects of probiotics on H. pylori eradication. Helicobacter pylori infection was detected in 64.2% children. Their mean age was 13.9±2.7 years. Helicobacter pylori eradication rate was 68.9% in group 1, and 66.6% in group 2 (p=0.78). No statistically significant difference was observed between the 2 groups in terms of side effects. None of the patients developed serious side effects mandating discontinuation of therapy.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Study design and characteristics of enrolled children in a study on Helicobacter pylori eradication in Turkey

see page 286

Oral steroid treatment for idiopathic sudden sensorineural hearing loss

Chen et al describe the efficacy of long-term oral steroids in idiopathic sudden sensorineural hearing loss (ISSHL), and to explore potential prognosis factors, the relationship of hearing recovery outcome, and the recovery time-course in ISSHL. The average pure-tone audiometry (PTA) was 67.8±23.9 dB initially, and was improved between one month (51.6±28.7 dB) and 2 months post treatment (49.7±28.6 dB). The average last-visit PTA was 49.9±29.2 dB. Approximately one third of patients had full recovery in hearing, one third had partial recovery, and approximately one third did not recover from hearing loss.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Recovery rates according to age and severity of hearing loss among ISSHL patients. ISSHL - Idiopathic sudden sensorineural hearing loss

see page 291

CASE REPORT

Successful treatment and follow-up of a case of recurrent pseudosarcomatous myofibroblastic proliferation

Lei et al describes a case of recurrent pseudosarcomatous myofibroblastic proliferation of the bladder with a satisfactory clinical course after a 3.5-year follow-up. For the primary lesion, a transurethral resection of the bladder tumor (TUR-BT) was performed; for the recurrent lesion, a combination regime of TUR-BT and intravesical mitomycin C proved effective treatment. The patient did not suffer local recurrence or distal metastasis during the 3.5-year follow-up.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Computed tomography scan of the recurrent lesion with a size of 2.0×1.0-cm, as indicated by the arrow. Perivesical invasion was not seen

see page 363

  • Copyright: © Saudi Medical Journal

This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PreviousNext
Back to top

In this issue

Saudi Medical Journal: 36 (3)
Saudi Medical Journal
Vol. 36, Issue 3
1 Mar 2015
  • Table of Contents
  • Cover (PDF)
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Saudi Medical Journal.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In this issueREVIEW ARTICLEORIGINAL ARTICLESCASE REPORT
(Your Name) has sent you a message from Saudi Medical Journal
(Your Name) thought you would like to see the Saudi Medical Journal web site.
Citation Tools
In this issueREVIEW ARTICLEORIGINAL ARTICLESCASE REPORT
Saudi Medical Journal Mar 2015, 36 (3) 271;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
In this issueREVIEW ARTICLEORIGINAL ARTICLESCASE REPORT
Saudi Medical Journal Mar 2015, 36 (3) 271;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • eLetters
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • In this issueSystematic ReviewOriginal ArticlesCase Report
  • In this issueSystematic ReviewOriginal Articles
  • In this issueClinical GuidelinesOriginal Articles
Show more Abstract

Similar Articles

CONTENT

  • home

JOURNAL

  • home

AUTHORS

  • home
Saudi Medical Journal

© 2025 Saudi Medical Journal Saudi Medical Journal is copyright under the Berne Convention and the International Copyright Convention.  Saudi Medical Journal is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work. Electronic ISSN 1658-3175. Print ISSN 0379-5284.

Powered by HighWire